Maze Therapeutics MAZE
NASDAQ MAZE
$32.44 +2.74 (+9.24%)
As of: Oct 20, 2026 · 3:59 PM EDT

Maze Therapeutics (MAZE) Retained Earnings (2024 - 2026)

Updated

Maze Therapeutics (MAZE) reported Retained Earnings of -$558.5 million for Q2 2026, compared with -$424.9 million a year earlier.

Analysis

Maze Therapeutics (MAZE) Retained Earnings (2024 - 2026) Analysis & Trends

At the end of FY2025, Maze Therapeutics posted Retained Earnings of -$489.55 million.

  • By year, Retained Earnings came in at -$358.43 million in FY2024.
  • Per Business Quant data, the three quarters before Q2 2026 came in at -$513.8 million (Q1 2026), -$489.55 million (Q4 2025) and -$455 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 31.89 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 171.67 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn -17.33 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 63.27 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn -
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 12.59 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn -22.28 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 2.20 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 112.09 Bn
10 Maze Therapeutics 1.91 Bn 417.43 Mn - -558.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -558.50 Mn
Mar 31, 2026 -513.80 Mn
Dec 31, 2025 -489.55 Mn
Sep 30, 2025 -455.00 Mn
Jun 30, 2025 -424.90 Mn
Mar 31, 2025 -391.21 Mn
Dec 31, 2024 -358.43 Mn
API Access

Maze Therapeutics Retained Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=retained-earnings&ticker=MAZE&period=max&api_key=YOUR_API_KEY